Recent Updates
Recently added Catalysts
COLL Positive Sentiment

Collegium to Participate in Jefferies Healthcare Conference

Thursday, June 1, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Collegium Pharmaceutical, Inc. (Nasdaq: COLL) will be participating in a fireside chat at the Jefferies Healthcare Conference in New York from June 7-9, 2023. The chat is scheduled for June 8, 2023, at 12:30 p.m. ET and will be webcast live, with an archived version available for 90 days post-event. This event indicates Collegium's ongoing commitment to engage with the investment community and foster transparency regarding its operations and initiatives.
Price reaction · baseline $22.07 (2023-05-31 close) · hit after-hours · clean, no other COLL news in the window
day 0 close · peak
+1.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Collegium is actively engaging with stakeholders at a prominent healthcare conference.
  • The company demonstrates commitment to transparency by providing a live webcast of the event.
  • Participation in the Jefferies Healthcare Conference highlights Collegium's position in the specialty pharmaceuticals sector.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+28%
120-day peak, hindsight
Typical move
0.4%
average across 3 past catalysts
Lead asset
DFN-15 Active
Phase 3 · Migraine Headache

Full Press Release Details

STOUGHTON, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference being held in New York, NY from June 7-9, 2023.
Details of the event are as follows:
Fireside Chat Date and Time: Thursday, June 8, 2023, at 12:30 p.m. ET
The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Christopher James, M.D.

Frequently Asked Questions

When is the Collegium Pharmaceutical fireside chat?

The fireside chat will take place on June 8, 2023, at 12:30 p.m. ET.

Where can I watch the fireside chat?

It will be available for live streaming on Collegium's Investors page.

How long will the webcast replay be available?

The replay will be accessible for 90 days after the presentation.

What is Collegium Pharmaceutical focused on?

Collegium specializes in improving lives affected by serious medical conditions.

Where is Collegium Pharmaceutical headquartered?

The company is headquartered in Stoughton, Massachusetts.

ShareAdd on Google
Tags: COLL Viatris Investor Conferences Healthcare Collegium Pharmaceutical Jefferies Healthcare Conference specialty pharmaceuticals investor relations Stoughton Massachusetts
Last updated: Jun 1, 2023

Biotech snapshot

Cash runway
$150M liquidity · $0M/mo burn
Low dilution risk
Lead asset
DFN-15 ActivePhase 3
Migraine Headache →

Catalyst track record

+28%
best trade around COLL's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for COLL.

See every catalyst's timing & PoA →